Williams Cancer Institute

02/17/2026

New research conversations are shaping how pancreatic cancer is being studied. In our upcoming video, we explore emerging scientific perspectives, the role of the immune system, and why timing and strategy may matter.
🎥 Coming soon on YouTube.

02/16/2026

Coming soon.
A thoughtful conversation exploring why cancer care cannot follow a one-size-fits-all model. The discussion examines patient variability, genetic differences, and how research and clinical experience are shaping more personalized, adaptive approaches to treatment—along with the regulatory and technological challenges involved.
🎥 Full video coming soon.
Stay tuned to learn more.

02/16/2026

Polyphenols and flavonoids—naturally found in fruits and plants—are being studied for their role in cancer research. These bioactive compounds may interact with pathways involved in oxidative stress, inflammation, and tumor biology. Ongoing research continues to explore their potential in integrative oncology.

  Cancer remains one of the leading causes of death worldwide and continues to represent a major challenge for modern […]

02/16/2026

Should medicine be delivered to the whole body—or to the tumor itself?

Most of the debate in oncology has focused on systemic delivery:
chemotherapy versus systemic immunotherapy.

But that framing misses a critical issue.

When medications are delivered systemically, only ~0.5–2% (often ~1%) actually reaches the tumor.
The rest is diluted, degraded, or diverted to healthy tissues—where toxicity accumulates.

And when tumor burden is large or multifocal, the challenge isn’t just reaching the tumor…
it’s penetrating the tumor microenvironment.

Systemic delivery comes with:
• Liver-first metabolism
• Non-tumor tissue exposure
• 98–99% of the associated toxicity

Intratumoral delivery changes the equation.

02/13/2026

🦠 Exploring the Gut–Immune Connection in Cancer Research

Could the microbiome influence how patients respond to immunotherapy? Learn how F***l Microbiota Transplantation (FMT) is being studied as part of emerging oncology research.

Read more here:
https://williamscancerinstitute.com/fecal-microbiota-transplantation-redefining-cancer-immunotherapy/

02/12/2026

Strategic combinations are revolutionizing cancer treatment. Here, you’ll discover how genetic and molecular-targeted drugs can enhance the effectiveness of immunotherapy, opening new opportunities for personalized treatments.
https://open.spotify.com/episode/7yySmeGIW0VHx1Q3enVU9g?si=FiKUiAeVTUuSMdti8tJsRQ

The Immunotherapy Revolution · Episode

02/11/2026

Discover a personalized approach to cancer care. At Williams Cancer Institute, we focus on intratumoral immunotherapy as part of a comprehensive, evidence-based medical strategy. Learn how individualized treatment planning and expert supervision guide every step of patient care.

02/11/2026

Immunotherapy is an evolving approach in cancer care, often used alongside other treatments as part of a personalized strategy. This content is for educational purposes only and does not replace medical advice.

02/10/2026

What if treating a tumor directly could be part of a personalized treatment approach?

At the Williams Cancer Institute, intratumoral immunotherapy may be combined with approaches such as PEF ablation or cryoablation within individualized care strategies, guided by medical evaluation.

02/10/2026

Cancer research is increasingly exploring polyphenols and flavonoids—natural compounds found in plants—for their ability to interact with multiple cancer-related pathways. While not a cure, ongoing studies suggest they may support conventional treatments and integrative oncology approaches.

  Cancer remains one of the leading causes of death worldwide and continues to represent a major challenge for modern […]

02/09/2026

Discover the power of Pulsed Precision in cancer care.

Our innovative approach combines advanced technology with personalized, physician-guided treatment to support your body’s natural defenses.

▶️ Swipe to learn how science and precision are shaping the future of cancer care. Follow for evidence-based insights.

02/09/2026

Fear around cancer treatment is real — especially when people hear about therapies delivered directly into a tumor.

Intratumoral immunotherapy is carefully studied and monitored in clinical settings, with safety and individual evaluation as priorities. This content is educational only, and outcomes may vary.